Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIFE | AMGN | CELG | GILD | BIIB |
| Company | Atyr Pharma Inc | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6800 | 272.14 | 108.01 | 67.09 | 193.34 |
| High | 1.6950 | 274.48 | 108.59 | 67.68 | 195.86 |
| Low | 1.6200 | 271.05 | 107.27 | 67.06 | 193.28 |
| Last | 1.6250 | 273.66 | 108.24 | 67.23 | 192.96 |
| Change | -0.0150 | +1.75 | +0.11 | +0.28 | -1.15 |
| % Change | -0.91% | +0.64% | +0.10% | +0.42% | -0.59% |
| Volume | 186,264 | 1,501,889 | 191,230,496 | 2,877,277 | 793,881 |
| 20-Day Average Volume | 399,165 | 2,165,095 | 16,188,930 | 6,213,188 | 1,145,870 |
| Previous Close | 1.6400 | 271.91 | 108.13 | 66.95 | 194.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7703 | 272.00 | 108.17 | 69.35 | 202.68 |
| 20-Day Raw Stochastic | 10.74% | 47.34% | 63.25% | 18.00% | 14.86% |
| 20-Day Relative Strength | 42.37% | 49.02% | 64.69% | 34.52% | 31.89% |
| Weighted Alpha | -19.39 | +11.64 | +46.30 | -20.36 | -38.38 |
| Today's Opinion | 24% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 40% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 88% Buy | 8% Buy | 100% Buy | 88% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.26% since 04/16/24 | +3.10% since 04/16/24 | -1.97% since 11/13/19 | +0.04% since 04/16/24 | -0.78% since 04/16/24 |
| Low | 1.5750 on 04/22/24 | 260.68 on 04/19/24 | 107.27 on 11/20/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.6850 on 04/22/24 | 274.48 on 04/23/24 | 110.53 on 11/14/19 | 67.68 on 04/23/24 | 196.77 on 04/22/24 |
| 1-Month | |||||
| %Chg | -16.39% since 03/22/24 | -0.83% since 03/22/24 | +5.14% since 10/18/19 | -7.26% since 03/22/24 | -11.22% since 03/22/24 |
| Low | 1.5750 on 04/22/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.0900 on 03/27/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 73.87 on 03/28/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | +5.86% since 01/23/24 | -11.63% since 01/23/24 | +13.63% since 08/20/19 | -15.28% since 01/23/24 | -23.07% since 01/23/24 |
| Low | 1.4800 on 02/02/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.1500 on 03/20/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 81.06 on 01/25/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +30.42% since 10/23/23 | +0.30% since 10/23/23 | +14.14% since 05/20/19 | -13.18% since 10/23/23 | -23.59% since 10/23/23 |
| Low | 1.0801 on 11/13/23 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.1500 on 03/20/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 111,423 | 145,845,984 | 77,035,920 | 83,357,904 | 28,216,022 |
| Shares Outstanding, K | 67,941 | 536,376 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 350,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -50,390,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 350,000 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -11,340,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 1.25 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 03/14/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 10.99 | 9.93 | 13.20 |